concentration agreement rates. Conclusions: Overall, the results indicate that the Phoenix system is a reliable system. It could provide accurate ID and AST results for routine clinical laboratories.
Materials and Methods

Bacterial Strains
Clinical isolates collected between 2000 and 2001 in the Prince of Wales Hospital, Hong Kong, were stored in cryotubes at -70 ° C. Different numbers of Gram-negative and Gram-positive strains were selected to set up a bacterial profi le that refl ected the projected ratio of different isolates in our routine clinical laboratory; 291 Gram-negative strains and 158 Gram-positive cocci were selected.
The Inoculating Procedures of the Phoenix System
Two hundred and ninety-one Gram-negative strains and 158
Gram-positive cocci were tested using the NMIC/ID-4 and the PMIC/ID-14 panels of the Phoenix system, respectively. Firstly, CrystalSPec nephelometer (Becton Dickinson, Sparks, Md., USA) was used to prepare the McFarland 0.5 bacterial suspension for the Phoenix ID tests in 4.5 ml of Phoenix ID broth. Then, the bacterial suspension for the Phoenix AST test was prepared by adding 25 l of bacterial ID suspension and one drop of AST indicator to 8 ml of Phoenix AST broth. The prepared bacterial ID and AST suspension was poured into the ID and AST sector of the Phoenix panels, respectively. Each biochemical reaction well on the panels was rehydrated with 50 l of bacterial suspension. Excess suspension was collected by the absorbent pad at the bottom of the panels. After sealing with a plastic cover and scanning the panel barcode, the panel was loaded manually into the Phoenix system.
Analysis of the ID Testing Results of the Phoenix System
The ID results of 291 Gram-negative strains and 158 Grampositive cocci of the Phoenix system were compared with those of the conventional API system as references. Afterwards, the correct ID rates to genus and species levels were calculated.
Analysis of the AST Results of the Phoenix System
Gram-negative strains were tested by the Phoenix system against 13 antimicrobial agents including amikacin (Bristol-Myers Squibb), ampicillin-sulbactam (Pfi zer), cefepime (Bristol-Myers Squibb), cefotaxime (Aventis), ceftazidime (GSK), chloramphenicol (Sigma), ciprofl oxacin (Bayer), gentamicin (Sigma), imipenem (MSD), meropenem (Astra Zeneca), moxifl oxacin (Bayer), piperacillin (Wyeth) and piperacillin-tazobactam (Wyeth). Gram-positive cocci including Staphylococcus spp. and Enterococcus spp. were tested against eight antimicrobial agents including ampicillin (Sigma), chloramphenicol, ciprofl oxacin, erythromycin (Sigma), moxifl oxacin, teicoplanin (Aventis), tetracycline (Sigma) and vancomycin (Lilly). Three additional drugs, oxacillin (Sigma), gentamicin (Sigma) and rifampicin (Sigma), were also tested against the Staphylococcus spp. Only AST results of 252 Gram-negative strains and 151 Gram-positive cocci (109 Staphylococcus spp. and 42 Enterococcus spp.) with correct IDs were compared with those of the MB method according to the National Committee for Clinical Laboratory Standards guidelines [9] . Minimum inhibitory concentration (MIC) agreement rates could show the accuracy of the Phoenix system. The rates were equal to the total number of strains minus the number of strains with the category agreement and discrepancy. The results were divided by the total number of strains tested and multiplied by 100%. 
Results
Identifi cation
The Phoenix system gave reproducible IDs after comparing with those of the API ID system. Among 291 Gram-negative bacteria tested, 266 (91.4%) were identifi ed correctly to species level ( table 1 ), while additional 18 organisms were correctly identifi ed to genus level; thus, the system had correct ID rate of 97.6% (284 out of 291) to genus level. Hence, only 7 organisms (2.4%) were misidentifi ed ( 
Antimicrobial Susceptibility Testing
The Phoenix system provided reproducible AST results after comparing with those of the MB method. For the 3,276 Gram-negative bacteria-antibiotic combinations, i.e. 252 strains tested against 13 antimicrobial agents, the agreement rates between the Phoenix MICs and the MB method MICs within 8 1 dilution ranged from 87.3 to 97.6% ( table 3 a). Only 20 (0.6%) and 4 (0.1%) results had major or very major discrepancies, respectively. One hundred and nine Staphylococcus spp. tested against 11 antimicrobial agents had a total of 1,199 bacteria-antibiotic combinations. The agreement rates between the Phoenix MICs and the MB method MICs within 8 1 dilution ranged from 54.6 to 100% ( table 3 b). Only 4 out of 1,199 bacteria-antibiotic combinations (0.3%) with major or very major discrepancies were found ( table 3 b). Three out of four major or very major discrepancies were found from oxacillin AST results (2 major and 1 very major discrepancies). For 336 bacteria-antibiotic combinations of the 42 Enterococcus spp., the agree-ment rates between the Phoenix MICs and the MB method MICs within 8 1 dilution ranged from 50.0 to 100% ( table 3 c). Only 6 out of 336 combinations (1.8%) had major or very major discrepancies. In both cases, vancomycin had low MIC agreement rates attributed to the high category agreement rates (interpretive category
Discussion
This study focused on the performance of the Phoenix Automated Microbiology System by testing Gram-negative bacilli and Gram-positive cocci commonly isolated in our routine clinical laboratory. The Phoenix system is composed of three major components including (a) a carousel-based panel transport system, (b) an optical reader capable of making both colorimetric and fl uorometric measurements as a function of time and (c) a data analysis process. The reaction panels contain chemicals and indicators that yield visible absorption or fl uorescence data for identifying the microorganisms. The principle of Phoenix AST is based on using oxidation-reduction reaction to monitor microbial metabolisms by the color changes of the indicator. If the organism is inhibited by an antimicrobial agent, there will be no dye reduction or color change. The instrument has the capacity holding 100 test panels. The results of the panel are read at 20-min intervals by the instrument. The fi nal interpretations of ID and AST results are available in 2-12 h and 4-12 h, respectively.
According to an evaluation of the Automated Phoenix System by Donay et al. [10] , the percentages of correct IDs were 93.3 and 89.4% for enterobacteria and nonfermenting Gram-negative bacilli, respectively, similar to our results. In our study, 5 out of 7 misidentifi ed Gramnegative bacilli were nonfermenters (2 Pantoea spp., 2 Chryseomonas spp . and 1 Alcaligenes xylosocidans ). The slower metabolism rates of nonfermenters caused weaker biochemical reactions in the reaction wells of the Phoenix panels, and therefore the ID results may be less reliable. The ID agreement rates of Staphylococcus spp. and Enterococcus spp. by Fahr et al. [8] were 97.1 and 98.9%, also similar to our fi ndings. The high ID agreement rates Total number of Gram-negative strains tested = 291. The rate of correct identifi cations after comparing with the API system to species level = 266/291 (91.4%). between the Phoenix system and the API system of both Gram-negative bacilli and Gram-positive cocci showed that the Phoenix system is also a reliability ID system. The overall AST category agreement rate of Gramnegative bacteria in our study is similar to that of Donay et al. [10] . The vancomycin MIC agreement rates of Staphylococcus spp. and Enterococcus spp. in the study by Fahr et al. [8] were 97.6 and 98.2%, respectively; they are higher than our fi ndings of 45.4% for Staphylococcus spp . and 50% for Enterococcus spp . All vancomycin MICs of the Phoenix system were higher than those of the MB method in all vancomycin category agreed but not MICagreed cases for both Staphylococcus spp. and Enterococcus spp. A possible explanation may be that the readings of the fi nal concentrations of the vancomycin in the reaction wells of the Phoenix PMIC/ID-14 panels were slightly but consistently lower. Hence, the vancomycin MICs of the Phoenix system were consistently higher than those of the MB method in all vancomycin category agreement cases for both Staphylococcus spp. and Enterococcus spp. Though only 0.3% (4 of 1,199 bacteria-antibiotic combinations) major or very major discrepancy was found for Staphylococcus spp., 3 of 4 discrepancies were found from the oxacillin AST results that were critical clinically. All discrepant AST results of vancomycin and oxacillin were repeated by both the Phoenix automated system and the MB method for verifi cation. This discrepancy requires further investigations.
As the Phoenix system is an open system, adding bacterial suspension to the testing panels manually may pose potential biohazard due to spillage. Sometimes, the panel covers may pop out in the incubation chamber. Despite these minor problems, the Phoenix system is an effi cient instrument that can greatly decrease the turnaround and hand-on time of routine clinical laboratories.
Conclusion
The results indicate that the Phoenix system is a reliable system that could provide accurate ID and AST results for routine clinical laboratories.
